Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Oliceridine by Trevena for Pain: Likelihood of Approval
Oliceridine is under clinical development by Trevena and currently in Phase II for Pain. According to GlobalData, Phase II drugs...